Cargando…

Breast carcinomas with low amplified/equivocal HER2 by Ish: potential supporting role of multiplex ligation-dependent probe amplification

BACKGROUND: This is a retrospective cross sectional study aimed to verify whether Multiplex Ligation-dependent Probe Amplification (MLPA), a quantitative molecular assay, may represent a valuable reflex test in breast cancer with equivocal HER2 expression by immunohistochemistry and HER2 gene signal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ercolani, Cristiana, Marchiò, Caterina, Di Benedetto, Anna, Fabi, Alessandra, Perracchio, Letizia, Vici, Patrizia, Sperati, Francesca, Buglioni, Simonetta, Arena, Vincenzo, Pescarmona, Edoardo, Sapino, Anna, Terrenato, Irene, Mottolese, Marcella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640946/ https://www.ncbi.nlm.nih.gov/pubmed/29029640 http://dx.doi.org/10.1186/s13046-017-0613-2

Ejemplares similares

HER2 Status Determination: Analyzing the Problems to Find the Solutions
por: Terrenato, Irene, et al.
Publicado: (2015)

A cut-off of 2150 cytokeratin 19 mRNA copy number in sentinel lymph node may be a powerful predictor of non-sentinel lymph node status in breast cancer patients
por: Terrenato, Irene, et al.
Publicado: (2017)

Not enough can be enough: feasibility of the Idylla EGFR mutation test when reuse of stained tissue slides is the only option available
por: Ercolani, Cristiana, et al.
Publicado: (2022)

A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study
por: Novelli, Flavia, et al.
Publicado: (2008)

Induction of ErbB-3 Expression by α6β4 Integrin Contributes to Tamoxifen Resistance in ERβ1-Negative Breast Carcinomas
por: Folgiero, Valentina, et al.
Publicado: (2008)

External Quality Assessment (EQA) program for the preanalytical and analytical immunohistochemical determination of HER2 in breast cancer: an experience on a regional scale
por: Terrenato, Irene, et al.
Publicado: (2013)

Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy
por: Vici, Patrizia, et al.
Publicado: (2016)

Quantitative assessments and clinical outcomes in HER2 equivocal 2018 ASCO/CAP ISH group 4 breast cancer
por: Gupta, Swati, et al.
Publicado: (2019)

A Real-World Systematic Analysis of Driver Mutations’ Prevalence in Early- and Advanced-Stage NSCLC: Implications for Targeted Therapies in the Adjuvant Setting
por: Terrenato, Irene, et al.
Publicado: (2022)

The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer
por: Benedetto, Anna Di, et al.
Publicado: (2016)

HMG-CoAR expression in male breast cancer: relationship with hormone receptors, Hippo transducers and survival outcomes
por: Di Benedetto, Anna, et al.
Publicado: (2016)

Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression
por: Di Benedetto, Anna, et al.
Publicado: (2017)

Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis
por: Vici, Patrizia, et al.
Publicado: (2015)

Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer
por: Barba, Maddalena, et al.
Publicado: (2017)

PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes
por: Lattanzio, Rossano, et al.
Publicado: (2019)

Quantitative Molecular Analysis of Sentinel Lymph Node May Be Predictive of Axillary Node Status in Breast Cancer Classified by Molecular Subtypes
por: Buglioni, Simonetta, et al.
Publicado: (2013)

The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment
por: Marchiò, Caterina, et al.
Publicado: (2018)

FuncISH: learning a functional representation of neural ISH images
por: Liscovitch, Noa, et al.
Publicado: (2013)

Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations
por: Allegretti, Matteo, et al.
Publicado: (2018)

Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy
por: Melucci, Elisa, et al.
Publicado: (2018)

DNA Damage and Repair Biomarkers in Cervical Cancer Patients Treated with Neoadjuvant Chemotherapy: An Exploratory Analysis
por: Vici, Patrizia, et al.
Publicado: (2016)

Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer
por: Pallocca, Matteo, et al.
Publicado: (2018)

Insulinoma with equivocal imaging
por: Belabed, Wafa, et al.
Publicado: (2023)

p53 status as effect modifier of the association between pre-treatment fasting glucose and breast cancer outcomes in non diabetic, HER2 positive patients treated with trastuzumab
por: Vici, Patrizia, et al.
Publicado: (2014)

Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting
por: Di Benedetto, Anna, et al.
Publicado: (2019)

GINI: From ISH Images to Gene Interaction Networks
por: Puniyani, Kriti, et al.
Publicado: (2013)

Localizing Genes to Cerebellar Layers by Classifying ISH Images
por: Kirsch, Lior, et al.
Publicado: (2012)

RNA Whole-Mount In situ Hybridisation Proximity Ligation Assay (rISH-PLA), an Assay for Detecting RNA-Protein Complexes in Intact Cells
por: Roussis, Ioannis M., et al.
Publicado: (2016)

An Equivocal SCC Lesion—Antiepileptic-Induced CLOCC
por: Kuczyńska, Maryla, et al.
Publicado: (2022)

The Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy
por: Vici, Patrizia, et al.
Publicado: (2014)

Observations in Support of Equivocal Generation
Publicado: (1811)

LDL-cholesterol targets as Achilles’ heel of 2020 ISH guidelines
por: Filipiak, Krzysztof J.
Publicado: (2021)

“Borderline” epithelial lesions of the breast: what have we learned in the past three decades?
por: Sapino, Anna, et al.
Publicado: (2021)

Claspin as a biomarker of human papillomavirus-related high grade lesions of uterine cervix
por: Benevolo, Maria, et al.
Publicado: (2012)

Are the guidelines of the ISH devoted to a population not contemplated in the ACC/AHA guidelines?
por: Ruilope, Luis M., et al.
Publicado: (2020)

Diagnostic Accuracy of Contrast-Enhanced, Spectral Mammography (CESM) and 3T Magnetic Resonance Compared to Full-Field Digital Mammography plus Ultrasound in Breast Lesions: Results of a (Pilot) Open-Label, Single-Centre Prospective Study
por: Ferranti, Francesca Romana, et al.
Publicado: (2022)

Ocular Equivocation: The Rivalry Between Wheatstone and Brewster
por: Wade, Nicholas J.
Publicado: (2019)

Is Peri-Operative Isolated Systolic Hypertension (ISH) a Cardiac Risk Factor?
por: Fayad, Ashraf, et al.
Publicado: (2008)

Evaluating of HPV–DNA ISH as an adjunct to p16 testing in oropharyngeal cancer
por: Chi, Jeffrey, et al.
Publicado: (2020)

EBV persistence in gastric cancer cases conventionally classified as EBER-ISH negative
por: Siciliano, M. C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jhhisf7pm00s1s7sjqjrnurj63